Strong Revenue Growth
Option Care Health reported a 16% increase in revenue over the first quarter of last year, with mid-teens growth in acute therapies and high teens growth in chronic therapies.
Adjusted EBITDA Growth
The company achieved a 13.7% growth in adjusted EBITDA year-over-year, reflecting disciplined spending and strong top-line performance.
Strategic Investments
Investments included opening a new compounding pharmacy, three infusion clinics, enhancing technology, and expanding nursing capabilities.
Intramed Plus Acquisition Integration Success
The acquisition of Intramed Plus is on track to meet financial and operational goals, expanding care models and infusion clinic footprint.
Advanced Technology Implementation
The company expanded the use of robotic process automation and machine learning, improving revenue cycle management and cash collection velocity.
Positive Outlook and Guidance
For 2025, the company expects to generate revenue of $5.4 billion to $5.6 billion and adjusted EBITDA of $455 million to $470 million.
Share Repurchase Program
Repurchased $100 million of stock during the quarter, reflecting confidence in the company's financial health and future prospects.